New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 9, 2012
05:04 EDTAAPL, ABT, CYS, AGNC, HSIC, SBUX, CYOU, PPL, AFCE, SWKS, GNRCJim Cramer's "Mad Money"
Jim Cramer said, "There are a few silver linings in the market." He reviewed the pros and cons of the market right now. Cons: The most obvious is the fiscal cliff. Disappointing earnings -- and expectations are still too high given the environment. Take Starbucks (SBUX). The company was trading in the low $50s when it reported over the summer, when expectations were too high. Shares pummeled into the mid $40s. It reported again with inline expectations and shares rallied back into the low $50s. Europe is another con against the market, said Cramer, but here, too, that's old news. Hurricane Sandy put a damper on the markets as well. But, after devastation come rebuilding. Cramer said the markets are clearly ratcheting down ahead of the fiscal cliff, but soon there will be capitulation, and that will be the time to buy, buy, buy. Looking for a stock that's both recession-proof and doesn't have anything to do with the fiscal cliff? Cramer said investors need to consider Abbott Labs (ABT), which has two catalysts helping to drive shares higher. Abbott will be splitting itself into two companies as of Jan. 1, 2013. Shares have already posted a 21% return since that news was announced, but Cramer said there's more to come now that the split is only 53 days away. Abbott Labs will have faster growth with a lower yield, while the new pharma company will have slower growth but a juicy 4% yield. Add those two companies together and they're worth $74/sh, said Cramer. The second catalyst is positive data on it's Hepatitis C treatment. That news will be relayed at an upcoming conference and should also help send shares higher. Cramer said with Abbott Labs trading at just 12.2x earnings with a 9% growth rate, he'd be a buyer through the end of the year. EXECUTIVE DECISION: Cramer once again spoke with Cheryl Bachelder, president and CEO of AFC Enterprises (AFCE), purveyors of the Popeye's Louisiana Kitchen chain of quick-serve restaurants. Shares of AFC are up 85% for the year and 14% since Cramer last spoke with Bachelder in August. Popeye's new flavorful menu is bringing excitement to the stores and is part reason for a 2c earnings beat on a 6.3% rise in same-store sales. Cramer once again praised Bachelder for a remarkable turnaround and growth story. He continues to recommend the stock. Cramer also sat down with Stanley Bergman, chairman and CEO of Henry Schein (HSIC), a medical products supplier to doctors, dentists and veterinarians. Henry Schein is active in acquisitions. The company does about 20 deals a year and currently has a full pipeline of deals in the works. Cramer reiterated his recommendation of Henry Schein, another recession-proof business he said will not be falling off the fiscal cliff in 2013. NO HUDDLE OFFENSE: Cramer said Apple (AAPL) is among those companies he's dubbed the "FCS" or fiscal cliff stocks, stocks that just make too much sense to sell now ahead of what will most likely be higher capital gains tax rates next year. Cramer said it would be greedy not to take something off the table now given Apple's big gains, which is why he's been taking profits in his trust of late. Once we get some clarity on the fiscal cliff, then we will know how to value Apple's growth. LIGHTNING ROUND: (Bullish) PPL; AGNC. (Bearish) GNRC; CYOU; CYS; SWKS. Reference Link
News For SBUX;ABT;AFCE;HSIC;AAPL;PPL;AGNC;GNRC;CYOU;CYS;SWKS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 >>
August 21, 2015
08:11 EDTAAPLDaimler AG could collaborate with Google, Apple, Reuters says
Subscribe for More Information
06:01 EDTAAPLABI Research: Portable PC sales to remain flat in 2015, DigiTimes says
Subscribe for More Information
August 20, 2015
16:00 EDTAAPLOptions Update; August 20, 2015
iPath S&P 500 VIX Short-Term Futures up 1.49 to 17.70. Option volume leaders: AAPL BAC FB NFLX DIS INTC BABA MU
12:24 EDTAAPLVIX methodology for Apple up 12% to 33.29
10:22 EDTAAPLApple falls, levels to watch
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:45 EDTAAPLApple iPhone 6S may not pressure gross margins, says Bernstein
Subscribe for More Information
06:13 EDTAAPLApple's Australian bonds raise $1.2B within two hours, SMH reports
Subscribe for More Information
06:07 EDTAAPLApple's 12.9-inch iPad to feature displays from Sharp, DigiTimes reports
Subscribe for More Information
August 19, 2015
19:13 EDTAAPLSamsung to ask Supreme Court to review Apple patent ruling
Samsung (SSNLF) has filed court documents indicating it will ask the U.S. Supreme Court to hear an appeal of its Apple (AAPL) patent fight. Reference Link
17:44 EDTAAPLApple iPhone 6s to feature stronger metal body, MacRumors says
Subscribe for More Information
16:08 EDTHSICLeidos awarded $4.3B DoD contract
Leidos (LDOS) was awarded a prime contract by the Department of Defense, or DoD, to provide an off-the-shelf electronic health record solution, integration activities and deployment across the Military Health System. The contract, known as the Defense Healthcare Management System Modernization, or DHMSM, program, is an initiative designed to modernize the military's healthcare system in a meaningful way, enabling patients and clinicians to capture and share health data that can improve the continuity and quality of care for 9.6M active military, their families, and their beneficiaries. As the prime contractor, Leidos established a team of proven innovators and industry leaders to form the Leidos Partnership for Defense Health. Cerner (CERN), Accenture Federal Services (ACN) and Henry Schein (HSIC) form the core team, complemented with a broad range of large and small business teammates, vendors and suppliers who bring proven experience and expertise specific to both the commercial and DoD healthcare markets.
16:00 EDTAAPLOptions Update; August 19, 2015
Subscribe for More Information
11:14 EDTAAPLApple to open first Middle East store this year, Bloomberg reports
Subscribe for More Information
09:33 EDTAAPLActive equity options trading on open
Active equity options trading on open: AAPL BAC FB BA TWTR NFLX WMT BABA
08:59 EDTGNRCGenerac management to meet with William Blair
Subscribe for More Information
07:52 EDTAAPLAnalog Devices growth being driven by Apple, says Jefferies
Subscribe for More Information
06:35 EDTAAPLApple Stores to shift iPod stock to shelves, drop iPad smart signs, 9to5Mac says
Apple plans to make changes at its stores by relocating iPod stock to accessory shelves and removing iPad-based Smart Signs, 9to5Mac reports, citing several Apple Retail managers briefed on the plans. Apple will start to roll out these changes overnight on Tuesday of next week in the U.S., the report says. Reference Link
06:12 EDTSBUXStarbucks K-cup momentum is accelerating, says UBS
UBS analyst Keith Siegner says Starbucks (SBUX) is seeing accelerating momentum in the single-serve cup category. The company's K-cup sales increased 36% year-over-year for the four-week period ended August 8, according to Nielsen (NLSN), Siegner tells investors in a research note. Starbucks' K-cup promotion levels ticked up sequentially, but remain well below levels from earlier in the year, the analyst points out. The company's K-Cup portfolio continues to gain share despite increasing price pressure and new market entrants like Dunkin' Brands (DNKN) and McDonald's (MCD), Siegner writes. He keeps a Buy rating on Starbucks with a $63 price target. The stock closed yesterday up 9c to $57.83. Shares of Keurig Green Mountain (GMCR) are down 62% year-to-date in part due to the company's slowing sales in the single-serve cup category.
05:50 EDTSWKSStocks with implied volatility movement; SWKS CNX
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use